Aclaris Therapeutics, Inc.

ACRS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001557746

SEC filings (opens in a new tab)

No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Aclaris Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of ACRS: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	128	149	+21
Shares	65.8M	71.6M	+5.77M (+8.8%)
Value	$1.04B	$579.3M	−$457.0M (−44.1%)

New holders (41)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to ACRS in Q1 2023
Institution	Shares	Value	% of portfolio
Bain Capital Life Sciences Investors, LLC	3,400,000	$27.5M	3.44%
Deep Track Capital, LP	1,708,971	$13.8M	0.59%
Samlyn Capital, LLC	1,051,568	$8.51M	0.16%
Octagon Capital Advisors LP	577,000	$4.67M	0.67%
Ghost Tree Capital, LLC	425,000	$3.44M	1.30%
Jefferies Financial Group Inc.	416,551	$3.37M	0.07%
Ikarian Capital, LLC	300,163	$2.43M	1.01%
Soleus Capital Management, L.P.	249,000	$2.01M	0.25%
Caption Management, LLC	221,104	$1.79M	0.38%
Jane Street Group, LLC	177,461	$1.44M	0.00%
Lion Point Capital, LP	109,898	$889.1K	0.49%
Group One Trading, L.P.	91,426	$739.6K	0.04%
Endurant Capital Management LP	83,891	$678.7K	0.35%
UBS Oconnor LLC	83,678	$677.0K	0.02%
Boothbay Fund Management, LLC	61,443	$497.1K	0.01%
Jacobs Levy Equity Management, Inc	59,460	$481.0K	0.00%
Weiss Multi-Strategy Advisers LLC	58,962	$477.0K	0.01%
Cubist Systematic Strategies, LLC	54,975	$444.7K	0.00%
Parallax Volatility Advisers, L.P.	48,434	$391.8K	0.01%
Man Group plc	–	$341.4K	0.00%
Two Sigma Advisers, LP	40,500	$327.6K	0.00%
Gsa Capital Partners LLP	32,358	$262.0K	0.03%
Belvedere Trading LLC	32,181	$260.3K	0.11%
Tudor Investment Corp Et Al	31,144	$252.0K	0.00%
Susquehanna International Group, LLP	28,476	$230.4K	0.00%
Axq Capital, LP	25,816	$208.9K	0.08%
PDT Partners, LLC	24,857	$201.1K	0.03%
Bridgefront Capital, LLC	21,938	$177.5K	0.11%
Engineers Gate Manager LP	21,725	$175.8K	0.01%
Janus Henderson Group PLC	20,389	$164.6K	0.00%
Ovata Capital Management Ltd	15,000	$121.3K	0.05%
Teacher Retirement System of Texas	14,380	$116.0K	0.00%
Vontobel Holding Ltd.	14,228	$115.1K	0.00%
Profund Advisors LLC	13,869	$112.2K	0.01%
Voloridge Investment Management, LLC	11,349	$91.8K	0.00%
Corton Capital Inc.	10,419	$84.3K	0.06%
Quantbot Technologies LP	8,700	$70.4K	0.00%
The PNC Financial Services Group, Inc.	726	$5.87K	0.00%
TCI Wealth Advisors, Inc.	528	$4.27K	0.00%
Quadrant Capital Group LLC	68	$551	0.00%
Advisor Group Holdings, Inc.	16	$129	0.00%

Sold out (20)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of ACRS in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
OrbiMed Advisors LLC	2,758,434	$43.4M
Perceptive Advisors LLC	341,239	$5.37M
Allspring Global Investments Holdings, LLC	65,307	$1.03M
Cheyne Capital Management (UK) LLP	50,964	$802.7K
HRT Financial LP	45,535	$717.0K
Walleye Trading LLC	22,009	$346.6K
Allianz Asset Management GmbH	21,800	$343.4K
Balyasny Asset Management LLC	20,503	$322.9K
Fox Run Management, L.L.C.	16,350	$257.5K
X-Square Capital, LLC	16,000	$252.0K
Alberta Investment Management Corp	15,093	$237.7K
ExodusPoint Capital Management, LP	14,753	$232.0K
XTX Topco Ltd	12,423	$195.7K
Aquatic Capital Management LLC	8,800	$139.0K
State of Wyoming	5,533	$87.1K
Point72 Middle East FZE	4,788	$75.4K
Quarry LP	1,124	$17.7K
Harbour Investments, Inc.	1,000	$15.8K
Lindbrook Capital, LLC	208	$3.28K
Glassman Wealth Services	16	$252